The grant will fund a study of new drug combinations for effectiveness against treatment-resistant ovarian cancer.
Research being done in Oklahoma could impact the lives of those dealing with ovarian cancer.
OMRF has discovered a targeted therapy that could improve treatment and long-term outcomes for ovarian cancer.
The funding will establish the Center for Cellular Metabolism Research in Oklahoma and supports five junior researchers.
The National Institutes of Health grants total nearly $2.1 million.
A trio of new principal scientists have joined OMRF.